Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent
- 28 June 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (13) , 11389-11400
Abstract
Hepatic stellate cells (HSCs) activation is a key event in the development of liver fibrosis, and blockage of the activation of HSCs has been shown to alleviate liver fibrosis. Sophoridine, a bioactive alkaloid found in many Chinese herbs, exhibits a broad spectrum of pharmacological effects, but its activities are not strong. In this study, a series of structurally modified derivatives of sophoridine were designed and synthesized. Among them, sophoridine alpha-aryl propionamide derivative ZM600 displayed a significant inhibitory effect on the activation of HSCs. The in vivo experiment demonstrated that ZM600 markedly ameliorated carbon tetrachloride (CCl4) and bile duct ligation (BDL)-induced liver fibrosis with a significant improvement of extracellular matrix deposition. Mechanism investigations revealed that ZM600 specifically inhibited the activation of NF-kappa B, PI-3K/AKT, and TGF-beta/Smads signaling pathways. These results suggest that ZM600 has a protective effect on liver fibrosis, which provides a new candidate for the treatment of liver fibrosis.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (21ZR1478000)
- Shanghai Municipal Health Commission (2022YQ049)
- National Natural Science Foundation of China (82200694, U20A20136)
This publication has 23 references indexed in Scilit:
- Sophoridine inhibits endotoxin-induced acute lung injury by enhancing autophagy of macrophage and reducing inflammationJournal of Leukocyte Biology, 2022
- Sophoridine: A review of its pharmacology, pharmacokinetics and toxicityPhytomedicine, 2022
- Anti-cancer potential of sophoridine and its derivatives: Recent progress and future perspectivesBioorganic Chemistry, 2020
- Antiviral activity of sophoridine against enterovirus 71 in vitroJournal of Ethnopharmacology, 2019
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issuesMolecular Aspects of Medicine, 2019
- Hepatic stellate cells as key target in liver fibrosisAdvanced Drug Delivery Reviews, 2017
- Mechanisms of hepatic stellate cell activationNature Reviews Gastroenterology & Hepatology, 2017
- Recent advancement of molecular mechanisms of liver fibrosisJournal of Hepato-Biliary-Pancreatic Sciences, 2015
- Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosisHepatology, 2014
- Synthesis and in vitro inhibitory activity of matrine derivatives towards pro-inflammatory cytokinesBioorganic & Medicinal Chemistry Letters, 2010